Skip to content

Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women

Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01737411
Acronym
URGE-I
Enrollment
120
Registered
2012-11-29
Start date
2013-01-31
Completion date
2018-06-30
Last updated
2015-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urge Urinary Incontinence

Keywords

surgery, solifenacin, urge urinary incontinence

Brief summary

The purpose of this study is to determine if pelvic surgery can improve urge urinary incontinence in women more than standard medical treatment.

Detailed description

Urge Urinary Incontinence affects 30% of postmenopausal women. The etiology is unknown therefore treatment is symptomatic. For that purpose the nerval stimulation of the bladder muscle is interfered by several drugs, e.g. solifenacin. We observed that the surgical repair of critical pelvic structures, i.e. the uteri-sacral ligaments (USL) can restore continence in a considerable number of patients. In this study the surgical treatment is compared with the solifenacin treatment. According to outcome after three months patients who are still incontinent are referred to the opposite treatment group. Outcome will be differentiated in cure (primary aim) and improvement of symptoms (secondary aim).

Interventions

DRUGsolifenacin
PROCEDUREcesa/vasa

surgical repair of USL

Sponsors

Klinikum der Universität Köln
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* urge urinary incontinence

Exclusion criteria

* stress urinary incontinence * cancer disease of the females genital tract * pregnancy * neurologic/psychological reasons for incontinence * body weight \>100kg * previous urogynecological surgery (TVT) * syndrome of dry overactive bladder (\>20 micturitions within 24 hours)

Design outcomes

Primary

MeasureTime frameDescription
cure from urge urinary symptoms12 monthsAt the start of the study urge symptoms are categorized from 0 (no symptom for the specific item) to 2 (worst expression of symptom). Cure is defined when sum of category points is 0, improvement is defined when category points are less after than before treatment

Secondary

MeasureTime frameDescription
cure from urge urinary symptoms12 monthsWhen the assigned first line treatment did not cure patients receive the treatment of the other arm (cross-over). Before cross-over urge symptoms of each patient are categorized from 0 (no symptom for the specific item) to 2 (worst expression of symptom). Cure is defined when sum of category points is 0, improvement is defined when category points are less after than before treatment

Other

MeasureTime frameDescription
stress incontinence12 monthsSome patients develop a stress incontinence after surgical treatment. That is controlled by provocation tests.

Countries

Germany

Contacts

Primary ContactWolfram H Jager, PhD
wolframjaeger@gmx.de0049221478
Backup ContactPeter S Mallmann, Phd
peter.mallmann@uk-koeln.de0049221478

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026